The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Prognostic role of filgrastim and derived neutrophil-to-lymphocyte ratio (dNLR) in the effectiveness of PD1/PDL1 inhibitors in previously treated non-small cell lung cancer.
 
Juan Francisco Marin Pozo
Speakers' Bureau - AstraZeneca Spain; Incyte; Roche/Genentech
 
Carmen Lucia Muñoz Cid
No Relationships to Disclose
 
Macarena Merino Almazán
No Relationships to Disclose
 
Raquel Claramunt García
No Relationships to Disclose
 
Elvira Marin Caba
No Relationships to Disclose
 
Encarnación Pérez Cano
No Relationships to Disclose
 
Ana Laura Ortega Granados
No Relationships to Disclose